Results 1 to 10 of about 6,217 (146)

Comparative Prognosis of Fungal Balls Versus Invasive Pulmonary Mucormycosis [PDF]

open access: yesInfection and Drug Resistance
Jiayu Wang,1– 4 Naishu Xie,1– 4 Rui Zhao,1– 4 Huihui Zeng,1– 4 Yan Chen1– 4 1Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Research Unit of ...
Wang J, Xie N, Zhao R, Zeng H, Chen Y
doaj   +2 more sources

A rare case of an immunocompetent patient with isolated pulmonary mucormycosis

open access: yesIDCases, 2023
As one of the most lethal infections caused by fungi, pulmonary mucormycosis usually affects patients who are immunocompromised. Isolated pulmonary mucormycosis in immunocompetent patients is very rare.This report describes a 65-year-old immunocompetent ...
Hamidreza Rouientan   +3 more
doaj   +3 more sources

Pulmonary mucormycosis: A case report

open access: yesIDCases, 2020
Mucormycosis is a rare fungal infection caused by Mucorales order fungi. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas, pulmonary mucormycosis is a rare manifestation in patients with ...
António Grilo Novais   +9 more
doaj   +3 more sources

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis

open access: yesMedical Mycology Case Reports, 2018
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino   +4 more
doaj   +3 more sources

Transcriptomic and proteomic profiling of pulmonary mucormycosis reveals a failed activation of host immune response [PDF]

open access: yesFrontiers in Immunology
IntroductionMucormycosis is one of the most life-threatening fungal infections with delayed diagnosis and limited antifungal treatments. The transcriptome and proteome of pulmonary mucormycosis have not been fully investigated.MethodsWe obtained lung ...
Jinjin Zhong   +10 more
doaj   +2 more sources

A case report of pulmonary mucormycosis

open access: yesAPIK Journal of Internal Medicine, 2020
Pulmonary mucormycosis is a relatively rare pulmonary fungal disease which is difficult to diagnose and lacks effective treatment. The present study reports that the case of a 57-year-old patient who was treated successfully for pulmonary mucormycosis in
Surajsingh Ravindra Taur   +2 more
doaj   +3 more sources

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19

open access: yesMedical Mycology Case Reports, 2021
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Andre K. Johnson   +3 more
doaj   +3 more sources

Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis. [PDF]

open access: yesPLoS ONE
BackgroundPulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes.
Junjun Wan   +3 more
doaj   +2 more sources

Clinical characteristics and prognoses of pulmonary mucormycosis in four children

open access: yesPediatric Investigation, 2019
Importance Pulmonary mucormycosis is life threatening and carries a poor prognosis. Identification of factors that improve prognosis is urgently necessary.
Siyuan Guo   +3 more
doaj   +2 more sources

Case Report: Pulmonary mucormycosis caused by Rhizopus microsporus in a patient with chronic obstructive pulmonary disease [PDF]

open access: yesFrontiers in Medicine
BackgroundWe report a rare case of pulmonary mucormycosis caused by Rhizopus microsporus, which is rare in patients with chronic obstructive pulmonary disease.
Shanshan Wang   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy